Skip to main content

Update on FDA Guidance Pertaining to COVID Variants

As noted, here’s a brief update pertaining to the new and updated guidance for developers of therapeutics, vaccines, and tests for COVID-19. These guidance outline FDA’s vision of a forward-looking, and flexible approach to the evolving nature of the pandemic. In an update to its guidance on EUAs for COVID-19 vaccines, the FDA details the […]

| 2 min read | Tagged: